Late Phase (USD 338.4B – USD 501.9B): Startups and technology-driven companies capture significant demand in emerging regions ...

A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic ...

Here's today's Strands answers and hints. These clues will help you solve The New York Times' popular puzzle game, Strands, ...

In response to the global increase in demand for food caused by demographic growth and population aging, a team of researchers from the Universitat Oberta de Catalunya (UOC) has made progress in ...

Heylist, a Montreal-based SaaS (Software as a Service) platform founded in January 2024, solves a critical gap in the influencer marketing space: connecting global brands with nano and ...

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development ...

A team of researchers from the University of Queensland are working to develop technology that could one day enable consumers ...

The "Global Advanced (Chemical) Recycling Market 2026-2040" report has been added to ResearchAndMarkets.com's offering.

Scientists built a nano-cage to house Rubisco, the slow enzyme driving photosynthesis, offering a path to boost energy conversion in staple crops.

Renal Cell Carcinoma (RCC): FDA approved oral Everolimus for advanced RCC after failure of sunitinib and/or sorafenib. Approval was based on RECORD-1 randomized phase III (everolimus 10 mg PO daily vs ...

Stay ahead with updates on the Arkansas Lithium Innovation summit, G7 talks, and U.S. strategies for critical minerals.

India-based Miraqules developed a nanotechnology that mimics blood clotting proteins to quickly stop heavy bleeding.